Handle With Care: Corvus Pharmaceuticals Inc (NASDAQ: CRVS)
Currently, there are 68.17M common shares owned by the public and among those 53.34M shares have been available to trade. The company’s stock has a 5-day price change of -3.32% and -14.67% over the past three months. CRVS shares are trading -34.77% year to date (YTD), with the 12-month market performance up to 60.09% higher. […]
Better Times Ahead For Corvus Pharmaceuticals Inc (NASDAQ: CRVS)?
Corvus Pharmaceuticals Inc (CRVS) concluded trading on Thursday at a closing price of $3.35, with 4.1 million shares of worth about $13.74 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -62.86% during that period and on May 08, 2025 the price saw a […]